Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Tele-Savvy: Spanish program for Latino caregivers of people with Alzheimer's

Official title: Tele-Savvy for Latino Caregivers

Run by University of Rochester · NCT07290387 · Data updated 2026-11-12

This program tests a Spanish-language, remote caregiver education program to help Latino adults who care for family members with Alzheimer's disease or related dementias improve caregiving skills and reduce stress.

More Dementia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment64 (estimated)
SponsorUniversity of Rochester
Academic / other
Locations1 site (Rochester, New York)
StatusRecruiting
StartedApril 17, 2026
Main results expectedApril 30, 2027
Study endsMay 31, 2027
Registry record updatedMay 14, 2026
Trial IDNCT07290387 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Hispanic/Latino adults (18+) who speak and read Spanish, provide at least four hours per week of care to a community-dwelling person with Alzheimer's disease or related dementias, have access to an internet-connected device, and are willing to join online group sessions and study interviews.

Probably not a fit

People who cannot use a tablet or smartphone, who are not Spanish literate, or who plan to move the care recipient to an institutional setting within six months are unlikely to benefit from this remote program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will culturally adapt the evidence-based Tele Savvy caregiver education program for Spanish-speaking Latino caregivers and deliver it remotely in a Stage 1b single-arm clinical trial. The intervention includes weekly group video sessions and asynchronous instructional videos, and participants complete study interviews before and after the program. The primary outcome is caregiver mastery, with secondary outcomes including caregiver stress burden, depressive symptoms, and self-efficacy. Eligible participants are Hispanic/Latino adults who speak and read Spanish, provide at least four hours per week of care to a community-dwelling person with Alzheimer’s disease or related dementias, and have internet access and a device.

Why it matters

Potential benefit: If successful, Latino caregivers may gain stronger caregiving skills, increased confidence, and reduced stress and depressive symptoms.

How similar studies have gone: Tele Savvy is an evidence-based caregiver education program with prior positive results in caregiver trials, but this specific culturally adapted version for Latino caregivers is novel and has limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Identify as Hispanic or Latino
* Age 18 years or older
* Spanish speaking and able to read and write in Spanish
* Provide at least four hours per week of care to a community dwelling loved one with Alzheimer's disease or related dementias
* Have access to an electronic device and internet
* Willing to participate in study interviews and intervention sessions

Exclusion Criteria:

* Physical or sensory conditions preventing use of a computer tablet or smartphone
* Planning to move the care recipient to an institutional setting within six months

Where it's running

  • University of Rochester School of Nursing
    Rochester, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.